LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

20/20 Biolabs, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAIDX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / AIDX COVERAGE

What’s moving 20/20 Biolabs, Inc. now

Current reporting with the operating signal separated from the noise.

01
20/20 Biolabs, Inc. Common Stock : AIDX

20/20 Biolabs, Inc. Common Stock : AIDX

Investors are testing whether 20/20 Biolabs, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest AIDX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-20 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-03-31 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-22 · Period 2026-07-16SEC ↗8-KMaterial company eventFiled 2026-07-01 · Period 2026-07-01SEC ↗8-KMaterial company eventFiled 2026-05-26 · Period 2026-05-19SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-23 · Period 2026-08-18SEC ↗DEFA14AOfficial SEC filingFiled 2026-06-23SEC ↗PRE 14AOfficial SEC filingFiled 2026-06-01 · Period 2026-06-01SEC ↗
EARNINGS / QUARTERLY TRACKER

20/20 Biolabs, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.